Weekly Policy Update: FDA Funding and Other News

FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry f...

Learn More

Weekly Policy Update: Medical Device Tax and Colorado State Budget

  Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President,...

Learn More

Weekly Policy Update: House Repeals Medical Device Tax

On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your r...

Learn More

Weekly Policy Update: Full Repeal of the Medical Device Tax Advocacy

This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for...

Learn More

Weekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews

CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While...

Learn More

Weekly Policy Update: Meeting with Congresswoman Degette

This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportuni...

Learn More

Weekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing

2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Govern...

Learn More

Weekly Policy Update: FDA Releases Important Guidances

The FDA recently announced the release of important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical...

Learn More

Weekly Policy Update: Drug Pricing News

This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summa...

Learn More

Weekly Policy Update: BIO International Convention and Voter Registration

This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to...

Learn More